Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daria Hazuda

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|January 11, 2021
In Vitro Pharmacokinetic/Pharmacodynamic Modeling of HIV Latency Reversal by Novel HDAC Inhibitors Using an Automated PlatformWilliam Newhard, Munjal Patel, Jason Cassaday, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a RepliconsFrederick C Lahser, Karin Bystol, Stephanie Curry, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Rational design and synthesis of selective BACE-1 inhibitorsStephen F Brady, Satendra Singh, Ming Chih Crouthamel, et al.
Journal of Virology|October 4, 2019
Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4<sup>+</sup> T CellsDeanna A Kulpa, Aarthi Talla, Jessica H Brehm, et al.
Antiviral Research|November 28, 2016
Identification of proximal biomarkers of PKC agonism and evaluation of their role in HIV reactivationSai Vikram Vemula, Jill W Maxwell, Alexey Nefedov, et al.
Science Translational Medicine|March 14, 2014
Postexposure protection of macaques from vaginal SHIV infection by topical integrase inhibitorsCharles Dobard, Sunita Sharma, Urvi M Parikh, et al.
Vaccine|July 25, 2020
Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primatesMorgan A Monslow, Sayda Elbashir, Nicole L Sullivan, et al.
The Journal of Biological Chemistry|April 10, 2003
Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activitiesMing-Tain Lai, Elizabeth Chen, Ming-Chih Crouthamel, et al.
Molecular and Cellular Neurosciences|September 19, 2006
A genome wide analysis of ubiquitin ligases in APP processing identifies a novel regulator of BACE1 mRNA levelsAmy S Espeseth, Qian Huang, Adam Gates, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2009
MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A proteaseNigel J Liverton, Steven S Carroll, Jillian Dimuzio, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
SLAS Discovery : Advancing Life Sciences R & D|January 11, 2021
In Vitro Pharmacokinetic/Pharmacodynamic Modeling of HIV Latency Reversal by Novel HDAC Inhibitors Using an Automated PlatformWilliam Newhard, Munjal Patel, Jason Cassaday, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a RepliconsFrederick C Lahser, Karin Bystol, Stephanie Curry, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Rational design and synthesis of selective BACE-1 inhibitorsStephen F Brady, Satendra Singh, Ming Chih Crouthamel, et al.
Journal of Virology|October 4, 2019
Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4<sup>+</sup> T CellsDeanna A Kulpa, Aarthi Talla, Jessica H Brehm, et al.
Antiviral Research|November 28, 2016
Identification of proximal biomarkers of PKC agonism and evaluation of their role in HIV reactivationSai Vikram Vemula, Jill W Maxwell, Alexey Nefedov, et al.
Science Translational Medicine|March 14, 2014
Postexposure protection of macaques from vaginal SHIV infection by topical integrase inhibitorsCharles Dobard, Sunita Sharma, Urvi M Parikh, et al.
Vaccine|July 25, 2020
Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primatesMorgan A Monslow, Sayda Elbashir, Nicole L Sullivan, et al.
The Journal of Biological Chemistry|April 10, 2003
Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activitiesMing-Tain Lai, Elizabeth Chen, Ming-Chih Crouthamel, et al.
Molecular and Cellular Neurosciences|September 19, 2006
A genome wide analysis of ubiquitin ligases in APP processing identifies a novel regulator of BACE1 mRNA levelsAmy S Espeseth, Qian Huang, Adam Gates, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2009
MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A proteaseNigel J Liverton, Steven S Carroll, Jillian Dimuzio, et al.
Pageof 6